European Union example instances - E2B(R3) testing files
Submitted by Anonymous (not verified) on 23 May 2025 - 14:04
European Union example instances - E2B(R3) testing files
Test cases (1a-10) RTFs
Submitted by Anonymous (not verified) on 23 May 2025 - 14:03
Test cases (1a-10) RTFs
EudraVigilance registration manual
Submitted by Anonymous (not verified) on 23 May 2025 - 14:02
EudraVigilance registration manual
EudraVigilance - EVWEB user manual
Submitted by Anonymous (not verified) on 23 May 2025 - 14:00
EudraVigilance - EVWEB user manual
Timetable: Type IB variation requiring linguistic review
Submitted by Anonymous (not verified) on 23 May 2025 - 13:42
Timetable: Type IB variation requiring linguistic review
Timetable: Type II variation and worksharing application monthly assessment
Submitted by Anonymous (not verified) on 23 May 2025 - 13:39
Timetable: Type II variation and worksharing application monthly assessment
Management Board meeting: 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, 13 March 2025
Submitted by Anonymous (not verified) on 23 May 2025 - 13:39
Management Board meeting: 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, 13 March 2025
Timetable: Type II variation and worksharing application assessment - ATMP
Submitted by Anonymous (not verified) on 23 May 2025 - 13:36
Timetable: Type II variation and worksharing application assessment - ATMP
HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 October 2025, 10:00 (CEST) to 9 October 2025, 16:10 (CEST)
Submitted by Anonymous (not verified) on 23 May 2025 - 13:33
HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 October 2025, 10:00 (CEST) to 9 October 2025, 16:10 (CEST)
Minutes of the Cancer Medicines Forum - March 2025
Submitted by Anonymous (not verified) on 23 May 2025 - 13:29
Minutes of the Cancer Medicines Forum - March 2025